White blood cells, 103 cells/μL |
2.95 |
3.60–10.50 |
Neutrophils, 103 cells/μL |
2.29 |
1.50–7.70 |
Lymphocytes, 103 cells/μL |
0.381 |
1.20–4.10 |
CD3+ (PAN T), %(103 cells/μL) |
83% (0.316) |
0.78–3.0 |
CD3+/α+β, %(103 cells/μL) |
99% (0.312) |
0.6–3.3 |
CD3/γ+δ+, %(103 cells/μL) |
<1% (<0.003) |
0.025–0.2 |
CD3+CD4-CD8-, %(103 cells/μL) |
<1% (<0.003) |
0.0069–0.074 |
CD4, %(103 cells/μL) |
30% (0.094) |
0.5–2.0 |
CD4+CD45 RA+ (Naïve), %(103 cells/μL) |
45% (0.042) |
0.1–2.3 |
CD4+CD45 RA-CCR7+ (Central memory), %(103 cells/μL) |
48% (0.045) |
0.18–1.1 |
CD4+CD45 RA-CCR7- (Effector memory), %(103 cells/μL) |
7% (0.006) |
0.013–0.22 |
CD4+CD45 RA+CCR7- (Terminal effector memory), %(103 cells/μL) |
<1% (<0.0009) |
0.000098–0.068 |
CD4+CD127-+CCR7+CD25++ (Regulatory), % (103 cells/μL) |
<1% (<0.0009) |
0.025–0.18 |
CD8, %(103 cells/μL) |
52% (0.164) |
0.2–1.2 |
CD8+CD45 RA+ (Naïve), %(103 cells/μL) |
45% (0.073) |
0.016–1.0 |
CD8+CD45 RA-CCR7+ (Central memory), %(103 cells/μL) |
1% (0.001) |
0.0047–0.12 |
CD8+CD45 RA-CCR7- (Effector memory), %(103 cells/μL) |
17% (0.028) |
0.04–0.64 |
CD8+CD45 RA+CCR7- (Terminal effector memory), % (103 cells/μL) |
37% (0.060) |
0.025–0.28 |
CD4/CD8 ratio |
0.58 |
1.00–2.70 |
CD56+16+CD3- (NK), %(103 cells/μL) |
13% (0.049) |
0.10–1.2 |
CD19 (PAN B), %(103 cells/μL) |
2.7% (0.010) |
0.064–0.82 |
CD19+IgD+CD27- (B naïve), %(103 cells/μL) |
64% (0.006) |
0.028–0.55 |
CD19+IgD+CD27+ (B memory), %(103 cells/μL) |
16.5% (0.001) |
0.0039–0.17 |
CD19+IgD-CD27+ (switched B memory), %(103 cells/μL) |
2.7% (0.0002) |
0.0045–0.13 |
CD19+CD21+CD38- (B CD21+low), %(103 cells/μL) |
1% (0.0001) |
0.0017–0.049 |
CD19+IgM++CD38++ (B transitional), %(103 cells/μL) |
<1% (<0.0001) |
0.0006–0.10 |
CD19+IgM-+CD38++ (B plasmablast), %(103 cells/μL) |
<1% (<0.0001) |
0.0007–0.020 |
IgM, g/L |
4.12 |
0.40–2.30 |
IgA, g/L |
0.08 |
0.70–4.00 |
IgG, g/L |
14.92 |
7.00–16.00 |
IgG1, g/L |
11.71 |
3.82–9.28 |
IgG2, g/L |
0.41 |
2.41–7.00 |
IgG3, g/L |
0.80 |
0.22–1.76 |
IgG4, g/L |
0.06 |
0.04–0.86 |